Literature DB >> 7019087

Immunization of rats with heat-labile enterotoxin provides uniform protection against heterologous serotypes of enterotoxigenic Escherichia coli.

F A Klipstein, R F Engert, J D Clements.   

Abstract

Rats immunized with Escherichia coli heat-labile (LT) enterotoxin, either in the form of the holotoxin derived from a transformed K-12 strain or the polymyxin-release form obtained from human strains which produce LT toxin alone (LT+/ST- [ST is heat-stable toxin)] or together with ST toxin (LT+/ST+), were challenged with viable organisms of 10 different serotypes, 5 LT+/ST- and 5 LT+/ST+. The serum antitoxin response was monitored by enzyme-linked immunosorbent assay, and the degree of protection was determined by challenge in ligated ileal loops. Immunization with the holotoxin provided a strong antitoxin response and protection against all 10 challenge strains. Immunization with toxin from the LT+/ST+ strain provided equally strong protection against all strains, but immunization with toxin from the LT+/ST- strain yielded only a weak antitoxin response, moderate protection against challenge with LT+/ST- strains, and no protection against LT+/ST- strains, increasing by fivefold the immunization dosage of the LT+/ST- toxin failed to enhance protection. These observations (i) establish the fact that immunization with the LT holotoxin provides uniformly strong protection against heterologous serotypes and (ii) indicate that, for reasons which remain to be determined, the immunogenicity of the polymyxin-release LT from an LT+/ST+ strain differs from that of an LT+/ST- strain.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7019087      PMCID: PMC351564          DOI: 10.1128/iai.32.3.1100-1104.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Human diarrheal disease caused by enterotoxigenic Escherichia coli.

Authors:  R B Sack
Journal:  Annu Rev Microbiol       Date:  1975       Impact factor: 15.500

2.  Synergistic protective effect in rabbits of immunization with Vibrio cholerae lipopolysaccharide and toxin/toxoid.

Authors:  A M Svennerholm; J Holmgren
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

3.  Characterization and development of cimetidine as a histamine H2-receptor antagonist.

Authors:  R W Brimblecombe; W A Duncan; G J Durant; J C Emmett; C R Ganellin; G B Leslie; M E Parsons
Journal:  Gastroenterology       Date:  1978-02       Impact factor: 22.682

4.  Cross-reactivity between heat labile enterotoxins of Vibrio cholerae and Escherichia coli in neutralization tests in rabbit ileum and skin.

Authors:  J Holmgren; O Söderlind; T Wadström
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1973-12

5.  Relationships among heat-labile enterotoxins of Escherichia coli and Vibrio cholerae.

Authors:  C L Gyles
Journal:  J Infect Dis       Date:  1974-03       Impact factor: 5.226

6.  Test for enterotoxigenic Escherichia coli using Y-1 adrenal cells in miniculture.

Authors:  D A Sack; R B Sack
Journal:  Infect Immun       Date:  1975-02       Impact factor: 3.441

7.  Suckling mouse model for detection of heat-stable Escherichia coli enterotoxin: characteristics of the model.

Authors:  R A Giannella
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

8.  Immunization with Escherichia coli enterotoxin protects against homologous enterotoxin challenge.

Authors:  R B Sack
Journal:  Infect Immun       Date:  1973-10       Impact factor: 3.441

9.  New surface-associated heat-labile colonization factor antigen (CFA/II) produced by enterotoxigenic Escherichia coli of serogroups O6 and O8.

Authors:  D G Evans; D J Evans
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

10.  Antigenic similarity of heat-labile enterotoxins from diverse strains of Escherichia coli.

Authors:  R B Sack; J L Froehlich
Journal:  J Clin Microbiol       Date:  1977-06       Impact factor: 5.948

View more
  9 in total

1.  Properties of cross-linked toxoid vaccines made with hyperantigenic forms of synthetic Escherichia coli heat-stable toxin.

Authors:  F A Klipstein; R F Engert; R A Houghten
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

2.  Properties of synthetically produced Escherichia coli heat-stable enterotoxin.

Authors:  F A Klipstein; R F Engert; R A Houghten
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

3.  Immunity to heat-labile enterotoxins of porcine and human Escherichia coli strains achieved with synthetic cholera toxin peptides.

Authors:  C O Jacob; R Arnon; R A Finkelstein
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

4.  Safety and immunogenicity of an enterotoxigenic Escherichia coli vaccine patch containing heat-labile toxin: use of skin pretreatment to disrupt the stratum corneum.

Authors:  Gregory M Glenn; Christina P Villar; David C Flyer; A Louis Bourgeois; Robin McKenzie; Robert M Lavker; Sarah A Frech
Journal:  Infect Immun       Date:  2007-01-29       Impact factor: 3.441

5.  Development of a vaccine of cross-linked heat-stable and heat-labile enterotoxins that protects against Escherichia coli producing either enterotoxin.

Authors:  F A Klipstein; R F Engert; J D Clements
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

6.  Protection against human and porcine enterotoxigenic strains of Escherichia coli in rats immunized with a cross-linked toxoid vaccine.

Authors:  F A Klipstein; R F Engert; J D Clements; R A Houghten
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

7.  Arousal of mucosal secretory immunoglobulin A antitoxin in rats immunized with Escherichia coli heat-labile enterotoxin.

Authors:  F A Klipstein; R F Engert; J D Clements
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

8.  Immunological and physicochemical characterization of heat-labile enterotoxins isolated from two strains of Escherichia coli.

Authors:  J D Clements; D C Flint; F A Klipstein
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

9.  Construction of a potential live oral bivalent vaccine for typhoid fever and cholera-Escherichia coli-related diarrheas.

Authors:  J D Clements; S El-Morshidy
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.